Patient Characteristics
| Characteristic | Data |
| Median age (y) | 72 (range, 52–90) |
| PSA level (ng/mL) | |
| Mean | 3.26 (SD, 3.06) |
| Median | 1.88 (range, 0.24–14.0) |
| Median PSA doubling time (mo) | 4.2 (range, 0.9–34.0) |
| Median PSA velocity (ng/mL/y) | 2.0 (range, 0.1–56.4) |
| Gleason score (n) | |
| 3 + 4 | 12 (24%) |
| 4 + 3 | 16 (32%) |
| 4 + 4 | 17 (34%) |
| 4 + 5 | 1 (2%) |
| 5 + 4 | 4 (8%) |
| Treatment at time of biochemical relapse (n) | |
| Radical prostatectomy only | 14 (28%) |
| Radical intent EBRT only | 8 (16%) |
| Hormone therapy only | 3 (6%) |
| Radical prostatectomy + salvage EBRT | 8 (16%) |
| Radical prostatectomy + hormone therapy | 4 (8%) |
| Radical prostatectomy + EBRT + hormone therapy | 7 (14%) |
| Radical intent EBRT + hormone therapy | 6 (12%) |